Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
6 analysts have expressed a variety of opinions on Alignment Healthcare (NASDAQ:ALHC) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 3 | 0 | 1 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 2 | 1 | 0 | 1 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 0 | 1 | 0 | 0 | 0 |
Analysts have set 12-month price targets for Alignment Healthcare, revealing an average target of $10.0, a high estimate of $12.00, and a low estimate of $7.00. This upward trend is apparent, with the current average reflecting a 26.58% increase from the previous average price target of $7.90.
A clear picture of Alignment Healthcare's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Michael Ha | Baird | Raises | Outperform | $11.00 | $10.00 |
Gary Taylor | TD Cowen | Raises | Buy | $10.00 | $8.00 |
Jessica Tassan | Piper Sandler | Raises | Overweight | $10.00 | $8.00 |
Andrew Mok | Barclays | Raises | Underweight | $7.00 | $4.50 |
Craig Jones | Stifel | Raises | Buy | $12.00 | $9.00 |
Michael Ha | Baird | Announces | Outperform | $10.00 | - |
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Alignment Healthcare's market position. Stay informed and make well-informed decisions with our Ratings Table.
Stay up to date on Alignment Healthcare analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Alignment Healthcare displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 47.34%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -3.52%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Alignment Healthcare's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -18.86%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Alignment Healthcare's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -3.56%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a high debt-to-equity ratio of 1.78, Alignment Healthcare faces challenges in effectively managing its debt levels, indicating potential financial strain.
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ALHC